Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.

Bauer J, Curtin JA, Pinkel D, Bastian BC.

J Invest Dermatol. 2007 Jan;127(1):179-82. Epub 2006 Aug 3.

2.

Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population.

Wu D, Wang M, Wang X, Yin N, Song T, Li H, Yu J, Wang DM, Zhao Z.

Am J Dermatopathol. 2011 Jun;33(4):341-4. doi: 10.1097/DAD.0b013e3181fb5bc7.

PMID:
21430505
3.

BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.

Salgado CM, Basu D, Nikiforova M, Bauer BS, Johnson D, Rundell V, Grunwaldt LJ, Reyes-Múgica M.

Pediatr Dev Pathol. 2015 Jan-Feb;18(1):1-9. doi: 10.2350/14-10-1566-OA.1. Epub 2014 Dec 9.

PMID:
25490715
4.

BRAF and NRAS mutations in melanoma and melanocytic nevi.

Poynter JN, Elder JT, Fullen DR, Nair RP, Soengas MS, Johnson TM, Redman B, Thomas NE, Gruber SB.

Melanoma Res. 2006 Aug;16(4):267-73.

PMID:
16845322
5.

Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.

Karram S, Novy M, Saroufim M, Loya A, Taraif S, Houreih MA, Rauscher B, Habib RH, Oberkanins C, Khalifeh I.

Am J Dermatopathol. 2013 Jun;35(4):412-8. doi: 10.1097/DAD.0b013e31826db181.

PMID:
23051629
6.

Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.

Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, Tolbert D, Berwick M, Busam K, Begg CB, Mattingly D, Ollila DW, Tse CK, Hummer A, Lee-Taylor J, Conway K.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):991-7.

7.

NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi.

Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, How-Kit A, Su X, Coulomb-L'Hermine A, Tost J, Mourah S, Aractingi S, Guégan S.

J Invest Dermatol. 2014 Apr;134(4):1067-74. doi: 10.1038/jid.2013.429. Epub 2013 Oct 15.

8.

Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.

Akslen LA, Puntervoll H, Bachmann IM, Straume O, Vuhahula E, Kumar R, Molven A.

Melanoma Res. 2008 Feb;18(1):29-35. doi: 10.1097/CMR.0b013e3282f32517.

PMID:
18227705
9.

BRAF and NRAS mutations in spitzoid melanocytic lesions.

Fullen DR, Poynter JN, Lowe L, Su LD, Elder JT, Nair RP, Johnson TM, Gruber SB.

Mod Pathol. 2006 Oct;19(10):1324-32. Epub 2006 Jun 23.

10.

BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han.

Qi RQ, He L, Zheng S, Hong Y, Ma L, Zhang S, Zhao L, Guo X, Wang Y, Yu JY, Fu L, Zhang W, Long T, Zhang C, Chen G, Lin J, Wang C, Zhou L, Mi Q, Weiland M, Chen JZ, McHenga SS, Wang YK, McHepange U, Wang Z, Chen HD, Gao XH.

J Invest Dermatol. 2011 May;131(5):1129-38. doi: 10.1038/jid.2010.405. Epub 2011 Feb 17.

11.

NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.

Tschandl P, Berghoff AS, Preusser M, Burgstaller-Muehlbacher S, Pehamberger H, Okamoto I, Kittler H.

PLoS One. 2013 Jul 8;8(7):e69639. doi: 10.1371/journal.pone.0069639. Print 2013.

12.

Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi.

Dessars B, De Raeve LE, El Housni H, Debouck CJ, Sidon PJ, Morandini R, Roseeuw D, Ghanem GE, Vassart G, Heimann P.

J Invest Dermatol. 2007 Jun;127(6):1468-70. Epub 2007 Feb 15.

13.

Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases.

Phadke PA, Rakheja D, Le LP, Selim MA, Kapur P, Davis A, Mihm MC Jr, Hoang MP.

Am J Surg Pathol. 2011 May;35(5):656-69. doi: 10.1097/PAS.0b013e31821375ea.

PMID:
21436676
14.

Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract.

Tseng D, Kim J, Warrick A, Nelson D, Pukay M, Beadling C, Heinrich M, Selim MA, Corless CL, Nelson K.

J Am Acad Dermatol. 2014 Aug;71(2):229-36. doi: 10.1016/j.jaad.2014.03.033. Epub 2014 May 17.

15.

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

Edlundh-Rose E, Egyházi S, Omholt K, Månsson-Brahme E, Platz A, Hansson J, Lundeberg J.

Melanoma Res. 2006 Dec;16(6):471-8.

PMID:
17119447
16.

Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.

van Dijk MC, Bernsen MR, Ruiter DJ.

Am J Surg Pathol. 2005 Sep;29(9):1145-51.

PMID:
16096402
17.

Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.

Indsto JO, Kumar S, Wang L, Crotty KA, Arbuckle SM, Mann GJ.

J Cutan Pathol. 2007 Jun;34(6):448-55.

PMID:
17518771
18.

BRAF mutations are common somatic events in melanocytic nevi.

Kumar R, Angelini S, Snellman E, Hemminki K.

J Invest Dermatol. 2004 Feb;122(2):342-8.

19.

Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia.

Yeh I, von Deimling A, Bastian BC.

J Natl Cancer Inst. 2013 Jun 19;105(12):917-9. doi: 10.1093/jnci/djt119. Epub 2013 May 20.

20.

In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation.

Venesio T, Chiorino G, Balsamo A, Zaccagna A, Petti C, Scatolini M, Pisacane A, Sarotto I, Picciotto F, Risio M.

Mod Pathol. 2008 Jun;21(6):716-26. doi: 10.1038/modpathol.2008.41. Epub 2008 Apr 11.

Supplemental Content

Support Center